A Public Option for Clinical Trials? Lessons from Convalescent Plasma
-
Published:2024
Issue:1
Volume:52
Page:98-100
-
ISSN:1073-1105
-
Container-title:Journal of Law, Medicine & Ethics
-
language:en
-
Short-container-title:J. Law. Med. Ethics
Author:
Roy Victor,Ross Joseph S.,Ramachandran Reshma
Abstract
AbstractThe case of clinical trials for convalescent plasma during COVID-19 illustrates important lessons for realizing public sector approaches to biomedical research and development. These lessons, centering on mission, transparency, and spillover effects, can be translated to wider efforts to develop a “public option” for clinical trials.
Publisher
Cambridge University Press (CUP)